Cooperative signaling between alpha(6)beta(4) integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion - PubMed (original) (raw)
. 2000 Apr 7;275(14):10604-10.
doi: 10.1074/jbc.275.14.10604.
Affiliations
- PMID: 10744756
- DOI: 10.1074/jbc.275.14.10604
Free article
Cooperative signaling between alpha(6)beta(4) integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion
D Gambaletta et al. J Biol Chem. 2000.
Free article
Abstract
We previously demonstrated that beta(4) integrin subunit overexpression increases in vitro invasiveness of NIH3T3 cells that have been transformed by ErbB-2 oncogene. We used this model to identify domains within the large beta(4) cytoplasmic domain that are involved in the interaction of alpha(6)beta(4) with ErbB-2, invasion, and phosphatidylinositol 3-kinase (PI3K) activation. For this purpose, we expressed deletion mutants of beta(4) that lacked either all or portions of the beta(4) cytoplasmic domain in NIH3T3/ErbB-2 cells. We also used an ecto-domain mutant in which most of the extracellular domain of beta(4) was replaced with a c-Myc tag. These transfectants were examined for their ability to invade Matrigel and their ability to activate PI3K, as well as for the ability of alpha(6)beta(4) to co-immunoprecipitate with ErbB-2. The results obtained revealed that a region of the beta(4) cytoplasmic domain between amino acids 854 and 1183 is critical for the ability of alpha(6)beta(4) integrin to increase invasion. Interestingly, the extracellular domain of beta(4) is not necessary for alpha(6)beta(4) to stimulate invasion. The association of alpha(6)beta(4) with ErbB-2 is dependent upon the beta(4) cytoplasmic domain and can occur in the absence of alpha(6)beta(4) heterodimerization. Finally, we observed strong activation of PI3K with beta(4) wild type and with those beta(4) deletion mutants that were able to stimulate invasion upon the expression in NIH3T3/ErbB-2 cells. In conclusion, our results establish that there is cooperation between alpha(6)beta(4) and ErbB-2 in promoting PI3K-dependent invasion and implicate a specific region of the beta(4) cytoplasmic domain (amino acids 854-1183) in this event.
Similar articles
- The alpha6beta4 integrin can regulate ErbB-3 expression: implications for alpha6beta4 signaling and function.
Folgiero V, Bachelder RE, Bon G, Sacchi A, Falcioni R, Mercurio AM. Folgiero V, et al. Cancer Res. 2007 Feb 15;67(4):1645-52. doi: 10.1158/0008-5472.CAN-06-2980. Cancer Res. 2007. PMID: 17308105 - Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines.
Falcioni R, Antonini A, Nisticò P, Di Stefano S, Crescenzi M, Natali PG, Sacchi A. Falcioni R, et al. Exp Cell Res. 1997 Oct 10;236(1):76-85. doi: 10.1006/excr.1997.3695. Exp Cell Res. 1997. PMID: 9344587 - The alpha 6 beta 4 integrin and epithelial cell migration.
Mercurio AM, Rabinovitz I, Shaw LM. Mercurio AM, et al. Curr Opin Cell Biol. 2001 Oct;13(5):541-5. doi: 10.1016/s0955-0674(00)00249-0. Curr Opin Cell Biol. 2001. PMID: 11544021 Review. - Signal transduction by the alpha 6 beta 4 integrin: charting the path between laminin binding and nuclear events.
Giancotti FG. Giancotti FG. J Cell Sci. 1996 Jun;109 ( Pt 6):1165-72. doi: 10.1242/jcs.109.6.1165. J Cell Sci. 1996. PMID: 8799807 Review. No abstract available.
Cited by
- Integrin α6β4 Confers Doxorubicin Resistance in Cancer Cells by Suppressing Caspase-3-Mediated Apoptosis: Involvement of N-Glycans on β4 Integrin Subunit.
Kariya Y, Gu J, Kariya Y. Kariya Y, et al. Biomolecules. 2023 Dec 6;13(12):1752. doi: 10.3390/biom13121752. Biomolecules. 2023. PMID: 38136623 Free PMC article. - Aberrant Neuregulin 1/ErbB Signaling in Charcot-Marie-Tooth Type 4D Disease.
Jiang LT, Chen YH, Huang JH, Tong WF, Jin LJ, Li LX. Jiang LT, et al. Mol Cell Biol. 2022 Jul 21;42(7):e0055921. doi: 10.1128/mcb.00559-21. Epub 2022 Jun 16. Mol Cell Biol. 2022. PMID: 35708320 Free PMC article. - Junctional epithelium and hemidesmosomes: Tape and rivets for solving the "percutaneous device dilemma" in dental and other permanent implants.
Fischer NG, Aparicio C. Fischer NG, et al. Bioact Mater. 2022 Mar 19;18:178-198. doi: 10.1016/j.bioactmat.2022.03.019. eCollection 2022 Dec. Bioact Mater. 2022. PMID: 35387164 Free PMC article. Review. - Targeting cancer stem cells via integrin β4.
Dobson HE, Ruan S, Chang AE, Wicha MS, Li Q. Dobson HE, et al. Oncotarget. 2021 Aug 31;12(18):1850-1858. doi: 10.18632/oncotarget.27977. eCollection 2021 Aug 31. Oncotarget. 2021. PMID: 34504657 Free PMC article. - EGFR-dependent tyrosine phosphorylation of integrin β4 is not required for downstream signaling events in cancer cell lines.
Te Molder L, Kreft M, Heemskerk N, Schuring J, de Pereda JM, Wilhelmsen K, Sonnenberg A. Te Molder L, et al. Sci Rep. 2021 Apr 21;11(1):8675. doi: 10.1038/s41598-021-88134-6. Sci Rep. 2021. PMID: 33883672 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous